Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07275125

Enrollment

Registered

2025-12-10

Start date

2025-12-30

Completion date

2026-06-30

Last updated

2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Resistant Epilepsy

Brief summary

To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

1 Years to 18 Years

Inclusion criteria

* Children aged 1-18 years. * Diagnosed with drug-resistant epilepsy according to ILAE definition.\[2\] * On KD for at least 6 months.

Exclusion criteria

* \- Patients with contraindicated metabolic/genetic conditions. * Non-compliance with KD . Patients on alternative dietary therapies (e.g., low glycemic diet)

Design outcomes

Primary

Measure	Time frame
1-Control of seizures(frequency and duration of seizures) . 2-Quality of life by pediatric quality of life inventory v4. 3-Cognitive function by stanford binet intelligence scale 5th edition. 4-Growth parameters (weight and height by BMI in kg/m^2)	6 month

Secondary

Measure	Time frame
to detect clinical predictors of seizures control ( frequency of attack and duration) in patients with drug resistant epilepsy using MAD.	6 month

Countries

Egypt

Contacts

Primary ContactMahmoud Saber Elsayed

Mm.ss.elsayed277@gmail.com00201069770585

Outcome results